| | | Sale of TCV-backed AxiomSL commands PE interest, How TPG’s thematic focus drove the creation Ellodi, a new specialty pharma business, Ex-Goldman exec’s deal-by-deal shop GHK Capital brings debut fund to market | | | | Tuesday, September 29, 2020 | | | | | Morning!
TPG formed a company called Ellodi Pharmaceuticals, which is developing a drug to treat Eosinophilic Esophagitis, or EoE. This is an allergic inflammatory disease that can lead to difficulty swallowing, narrowing of the esophagus and potentially choking to death on food impaction, according to Sarah Pringle on PE Hub. Read it here on PE Hub. |
|
| | | Top Scoops | | | | Technology Crossover Ventures is attracting private equity interest for its portfolio company AxiomSL, which provides software for legal functions at financial institutions, writes Milana Vinn. Read it here. |
|
| | GHK Capital, launched by an ex-Goldman Sachs executive that has been working deal-by-deal since 2018, is in market with its debut fund, I write on Buyouts today. GHK was formed by Gilbert Klemann in 2018. The firm launched Fund I right into the pandemic, and has found success raising capital remotely. Read it here on Buyouts.
Have a great day! Reach me with your thoughts, tips, gossip, whatever at [email protected], on Twitter or find me on LinkedIn.
HOUSEKEEPING: Deadline extension! Invitation to Perspectives 2021
In its ninth year, Perspectives is Buyouts's annual study of how institutional investors will approach private equity over the coming year. If you are an institutional investor, your participation in the study is greatly appreciated.
CLICK HERE TO PARTICIPATE. Deadline to participate: 03 October, 2020
Participating takes less than 10 minutes (I promise!) and in return you will be provided with a complimentary copy of the full results of the study. A $5 donation to UNICEF will be made for every completed set of responses, with your answers remaining strictly anonymous. For any questions, please email Nicole Douglas, Head of Investor Research: [email protected] | | |
|
| | | | | | | | | | | | | | | | | Fluree wraps up seed round at $6.5m | | Fluree in North Carolina has closed its seed round at $6.5m to provide a platform for blockchain-secured data. Investors include 4490 Ventures, Rise of the Rest, Good Growth Capital, Engage Ventures and Ray Rothrock. More... |
| | | | | | |
|
| To update your PE Hub email preferences, or to unsubscribe, click here. |
| | | |
|
